Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of insulin glargine effects on myocardial function and metabolism in type 2 diabetes with primary left ventricular dysfunction
2004-002729-34Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of insulin glargine in type 2 diabetes mellitus (T2DM) and left ventricular dysfunction, sponsored by Sanofi. Primary endpoint: Change in myocardial glucose uptake. Started Jul 2007; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)left ventricular dysfunction
Beyond the preview
Go deeper on 2004-002729-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002729-34.